REVIEW ON MOLECULAR DOCKING - AN IN-SILICO METHOD USED TO DETERMINE THE BINDING AFFINITY OF LIGAND TO ANY RECEPTOR

Globally, cardiovascular diseases (CVDs) are now the primary cause of death and disability, especially in low- and middle-income nations. Genetic, behavioral, and environmental risk factors are mostly responsible for hypertension, a crucial factor in the advancement of cardiovascular disease. High blood pressure, commonly referred to as hypertension, is a leading cause of mortality worldwide and poses a major risk for cardiovascular diseases. ACE, which stands for Angiotensin I Converting Enzyme, has been recognized as an essential element of the renin-angiotensin system. Its primary role is to convert angiotensin I into angiotensin II while breaking down bradykinin. The technique of molecular docking can be utilized to illustrate how a small molecule interacts with a protein on an atomic scale, enabling us to understand the behavior of small molecules within the binding sites of specific proteins and to reveal key biochemical mechanisms. To summarize, our research offers new and clearer perspectives on the interaction characteristics of known potential ACE inhibitors.